CLINICAL_TRIALS
withdrawal
· 2022-06-13
Clinical Trial Update: Effect of Intracameral Phenylephrine/Ketorolac on Intraoperative Pain [Phase 4]
Summary
Phase 4 trial investigating intracameral phenylephrine/ketorolac for intraoperative pain has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Florida | Conditions: Pain Reduction | Phase 4 | Status: WITHDRAWN